The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
Matrix metalloproteinase 2 (MMP-2) plays a crucial role in the progression of breast cancer (BC). The prognostic role of MMP-2 expression in BC patients has been widely reported, but the results were inconsistent. Thus, a meta-analysis was conducted to gain a better insight into the impact of MMP-2...
Main Authors: | Yiping Chen, Xiaochen Wang, Guodi Chen, Caixia Dong, Depu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4376789?pdf=render |
Similar Items
-
The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
by: Agnė Bartnykaitė, et al.
Published: (2022-08-01) -
The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics
by: Hsien-Cheng Huang, et al.
Published: (2022-07-01) -
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis
by: Miao S, et al.
Published: (2015-07-01) -
Is the expression of matrix metalloproteinases (MMP-2, -9) and tissue inhibitors of metalloproteinases (TIMP-1, -2, and -3) associated with angiogenesis and clinicopathological features for breast cancer?
by: Suada Kuskunović-Vlahovljak, et al.
Published: (2017-12-01) -
Matrix metalloproteinases as therapeutic targets in breast cancer
by: Mi Jeong Kwon, et al.
Published: (2023-01-01)